Abstract
Introduction
Subclinical hypothyroidism is defined as elevated serum thyrotropin (TSH) levels with normal free T4 levels. Prevalence of subclinical hypothyroidism has a range of 2% to 5% in pregnant women [1] [2] [3] [4] . This clinical condition has a clear importance because the spectrum of thyroid disorders begins with subclinical hypothyroidism. SH is the first step of overt hypothyroidism and overt maternal hypothyroidism is directly associated with intellectual disorders during childhood in addition to severe pregnancy complications [5, 6] . Furthermore, hypothyroidism has adverse effects in almost all steps of lipid metabolism, causes hypercholesterolemia [7, 8] as another risk factor of atherosclerosis. So as a conclusion, hypothyroidism is suggested as a risk factor of cardiovascular events for whole population.
Although it is not clear the cutoff values for increased mean platelet volume (MPV) in prediction of cardiovascular risk but large platelets may casting in the pathogenesis of cardiovascular disease [9] [10] [11] In the literature, there is conflicting data about how SH affects MPV [12] [13] [14] . The aim of this study was to evaluate the MPV levels in pregnants with SH who have low cardiovascular risk.
Materials and Methods
A total of 70 pregnants with SH and 40 healthy pregnants who were followed up by the Department of Obstetrics and Gynecology at the Gulhane Military Medical Faculty, between January 2011 and March 2013, without known cardiovascular risk factors were included in our study, retrospectively. Patients with hypertension, diabetes mellitus, anemia, smoking, ongoing infection, having a history for antiplatelet and antilipid therapy or any of chronic diseases were excluded. Age, height, pre-pregnancy weight, pre-pregnancy body mass indexes (BMI), platelet count (PLT), mean corpuscular volume (MCV), hemoglobin (Hgb), hematocrit (Hct), red blood cell (RBC), red cell distribution width (RDW), mean platelet volume (MPV) , platelet distribution width (PDW), TSH, fT3, fT4 levels were all recorded.
SPSS for windows 15.0 software was used for statistical analysis. Data were defined as mean + standard deviation (SD). Groups were compared with one-way (ANOVA) for variables that show a normal distribution and with Mann-Whitney U test for variables that did not show a normal distribution. Bonferoni correction was also performed. Pearson correlation test was used for correlation analysis. Statistical significance was defined as p < 0.05. and thrombocyte parameters (Plt, MPV, PCT, RDW, PDW) were not statistically significantly different between pregnants with SH and healthy pregnants (p>0.05) ( Table 2 ). Mean fT3 and TSH levels of subclinical hypothyroidic pregnants were statistically significantly different from healthy pregnant (p=0.04 and p<0.01 respectively). In first trimester; Hgb, Hct, MCV, fT3 and TSH levels were statistically significantly different between two groups (p<0.05). In second trimester only TSH levels were statistically significantly different between two groups (p<0.05) and in the third trimester, there was no difference between two groups (p>0.05) ( Table 3 ). 
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Discussion
Our study has shown that platelet, MPV, PCT, PDW levels are not different in pregnants with subclinical hypothyroidism, who have no confounding factors such as hypertension, diabetes mellitus, anemia, smoking, ongoing infection, having a history for anti-platelet and anti-lipid therapy or any of chronic diseases, in comparison with healthy pregnants. Therefore, including only subclinical hypothyroid pregnants free from any confounding factor is an important feature of the present study.
In normal pregnancy, an increase in platelet aggregation and a decrease in the number of circulating platelets with gestation occur [15, 16] . Also, platelet lifespan declines and the MPV increase minimally during pregnancy. These physiological changes are related to increased consumption of platelets in the uteroplacental circulation [17, 18] . Thyroid hormones affect the MPV levels of general population as normal pregnant women. To our knowledge, there
has not been any previous study about MPV levels in subclinical hypothyroidic pregnants. So, this is the first study which evaluates MPV levels in pregnants with subclinical hypothyroidism.
Studies concerning about the prognostic and diagnostic usefulness of MPV is still ongoing.
Platelet volume is a marker of platelet function and activation and measured as MPV by hematological analyzers [19] . Larger platelets are more reactive than smaller ones and produce more tromboxane A2, which is specific to thrombocytes and then it finally causes vasoconstriction and vein occlusion, prostacylin concentration decrease and vasoconstriction at vascular vein can occur [20] . These alterations can threaten both maternal and fetal life seriously.
According to our results, MPV levels were not statistically significantly different in the, age and BMI matched (Table 1) , subclinical hypothyroidic pregnants group than in euthyroidic control pregnants group. Also platelet counts, RDW, PCT, PDW levels were not different between two groups (Table 2) . These results let us to think that, subclinical hypothyroidism may not affect the platelet functions of pregnants. Also in subclinical hypothyroidic pregnant group, platelet counts, RDW, PCT, PDW levels were not different between all trimesters (Table 3) . Only, tyhroid functions and erythrocyte parameters were different between all trimesters. These differences may be related to subclinical hypothyroidism and physiological There are some limitations of the present study. Firstly, this is a retrospective observational study and we included only one cross-sectional value of MPV. Secondly, the results are valid for only Caucasians. Further epidemiological studies are needed to reveal exact values in different races and societies. Thirdly, because of limited sample size and the strict inclusion criteria, our findings are not representative for all subjects with SH. Fourthly, in most of our patients with subclinical hypothyroidism had autoimmune thyroiditis. Also, the best time interval for MPV determination is within 2 hours after obtaining of blood samples but this interval could not be achieved. Despite the limitations, our study is the first study to date evaluating the MPV levels in pregnants with SH.
In conclusion, our results suggest that pregnants with subclinical hypothyroidism do not tend to have increased platelet activation, in other words platelet, MPV, PCT, PDW levels are not different in pregnants with subclinical hypothyroidism in comparison with healthy pregnants.
Further prospective researches including large numbers of patients are required to evaluate the platelet activation in pregnants with subclinical hypothyroidism. 
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